203 related articles for article (PubMed ID: 20505189)
1. NF1 inactivation in adult acute myelogenous leukemia.
Parkin B; Ouillette P; Wang Y; Liu Y; Wright W; Roulston D; Purkayastha A; Dressel A; Karp J; Bockenstedt P; Al-Zoubi A; Talpaz M; Kujawski L; Liu Y; Shedden K; Shakhan S; Li C; Erba H; Malek SN
Clin Cancer Res; 2010 Aug; 16(16):4135-47. PubMed ID: 20505189
[TBL] [Abstract][Full Text] [Related]
2. NF1 inactivation revs up Ras in adult acute myelogenous leukemia.
Mullally A; Ebert BL
Clin Cancer Res; 2010 Aug; 16(16):4074-6. PubMed ID: 20587590
[TBL] [Abstract][Full Text] [Related]
3. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
[TBL] [Abstract][Full Text] [Related]
4. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
[TBL] [Abstract][Full Text] [Related]
5. Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia.
Parkin B; Erba H; Ouillette P; Roulston D; Purkayastha A; Karp J; Talpaz M; Kujawski L; Shakhan S; Li C; Shedden K; Malek SN
Blood; 2010 Dec; 116(23):4958-67. PubMed ID: 20729466
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M
Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia.
Boudry-Labis E; Roche-Lestienne C; Nibourel O; Boissel N; Terre C; Perot C; Eclache V; Gachard N; Tigaud I; Plessis G; Cuccuini W; Geffroy S; Villenet C; Figeac M; Leprêtre F; Renneville A; Cheok M; Soulier J; Dombret H; Preudhomme C;
Am J Hematol; 2013 Apr; 88(4):306-11. PubMed ID: 23460398
[TBL] [Abstract][Full Text] [Related]
8. Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice.
Cutts BA; Sjogren AK; Andersson KM; Wahlstrom AM; Karlsson C; Swolin B; Bergo MO
Blood; 2009 Oct; 114(17):3629-32. PubMed ID: 19710506
[TBL] [Abstract][Full Text] [Related]
9. Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia.
García-Ortí L; Cristóbal I; Cirauqui C; Guruceaga E; Marcotegui N; Calasanz MJ; Castello-Cros R; Odero MD
PLoS One; 2012; 7(10):e47717. PubMed ID: 23077663
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.
Kalra R; Paderanga DC; Olson K; Shannon KM
Blood; 1994 Nov; 84(10):3435-9. PubMed ID: 7949098
[TBL] [Abstract][Full Text] [Related]
11. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.
Balgobind BV; Van Vlierberghe P; van den Ouweland AM; Beverloo HB; Terlouw-Kromosoeto JN; van Wering ER; Reinhardt D; Horstmann M; Kaspers GJ; Pieters R; Zwaan CM; Van den Heuvel-Eibrink MM; Meijerink JP
Blood; 2008 Apr; 111(8):4322-8. PubMed ID: 18172006
[TBL] [Abstract][Full Text] [Related]
12. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
[TBL] [Abstract][Full Text] [Related]
13. CD82 regulates STAT5/IL-10 and supports survival of acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
Int J Cancer; 2014 Jan; 134(1):55-64. PubMed ID: 23797738
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia.
Garicochea B; Giorgi R; Odone VF; Dorlhiac-Llacer PE; Bendit I
Leuk Res; 1998 Nov; 22(11):1003-7. PubMed ID: 9783802
[TBL] [Abstract][Full Text] [Related]
15. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.
Al-Mawali A; Pinto AD; Al-Zadjali S
Acta Haematol; 2017; 138(3):175-181. PubMed ID: 29065396
[TBL] [Abstract][Full Text] [Related]
16. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
Heller PG; Glembotsky AC; Gandhi MJ; Cummings CL; Pirola CJ; Marta RF; Kornblihtt LI; Drachman JG; Molinas FC
Blood; 2005 Jun; 105(12):4664-70. PubMed ID: 15741216
[TBL] [Abstract][Full Text] [Related]
17. Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia.
Quesnel B; Preudhomme C; Vanrumbeke M; Vachee A; Lai JL; Fenaux P
Leukemia; 1994 May; 8(5):878-80. PubMed ID: 8182944
[TBL] [Abstract][Full Text] [Related]
18. NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome.
Eisfeld AK; Kohlschmidt J; Mrózek K; Mims A; Walker CJ; Blachly JS; Nicolet D; Orwick S; Maharry SE; Carroll AJ; Powell BL; Kolitz JE; Wang ES; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
Leukemia; 2018 Dec; 32(12):2536-2545. PubMed ID: 29872168
[TBL] [Abstract][Full Text] [Related]
19. CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles.
Oyan AM; Bø TH; Jonassen I; Ulvestad E; Gjertsen BT; Kalland KH; Bruserud O
Cytometry B Clin Cytom; 2005 Mar; 64(1):18-27. PubMed ID: 15668952
[TBL] [Abstract][Full Text] [Related]
20. Mutation Screening of Her-2, N-ras and Nf1 Genes in Brain Tumor Biopsies.
Yapijakis C; Adamopoulou M; Tasiouka K; Voumvourakis C; Stranjalis G
Anticancer Res; 2016 Sep; 36(9):4607-11. PubMed ID: 27630302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
